Company Filing History:
Years Active: 2022-2025
Title: Zelah Joel: Innovator in Pharmaceutical Formulations
Introduction
Zelah Joel is a prominent inventor based in London, GB, known for his significant contributions to the field of pharmaceutical formulations. With a total of 12 patents to his name, he has made remarkable strides in developing innovative therapies for psychiatric and neurological disorders.
Latest Patents
Zelah Joel's latest patents include groundbreaking work on injectable and inhalable formulations. These aqueous pharmaceutical formulations consist of a salt of an optionally substituted dimethyltryptamine compound and water, with a pH ranging from 5 to 6.5. The formulations are designed to deliver an effective dose of the compound for use in psychedelic-assisted therapy within a volume of 5 ml or less. They are suitable for both intramuscular injection and nebulized inhalation, demonstrating stability and clinical acceptability. Additionally, he has developed deuterated or partially deuterated N,N-dimethyltryptamine compounds, which offer tailored therapeutic effects for treating psychiatric or neurological disorders.
Career Highlights
Throughout his career, Zelah Joel has worked with notable companies such as Small Pharma Ltd and Cybin UK Ltd. His innovative approaches and dedication to research have positioned him as a key figure in the pharmaceutical industry.
Collaborations
Zelah has collaborated with talented individuals in his field, including Peter Rands and Tiffanie Benway, who have contributed to his research and development efforts.
Conclusion
Zelah Joel's work in pharmaceutical formulations showcases his commitment to advancing therapeutic options for mental health treatment. His innovative patents and collaborations highlight his significant impact on the industry.